Global bioprocessing boost for Merck | Chemical & Engineering News
Volume 95 Issue 3 | p. 11 | Concentrates
Issue Date: January 16, 2017

Global bioprocessing boost for Merck

Department: Business
Keywords: biologics, bioprocessing, Merck
[+]Enlarge
Merck will add more biodevelopment centers like the one here in Martillac, France.
Credit: Merck
A photo of Merck’s biodevelopment center in Martillac, France.
 
Merck will add more biodevelopment centers like the one here in Martillac, France.
Credit: Merck

Merck KGaA is planning to build biologic drug development centers near Boston and Shanghai following the success of a similar center in Martillac, France. The new centers will provide bioprocessing services including cell line development, process development, and non-Good Manufacturing Process (GMP) clinical production. Additionally, Merck will beef up the Martillac center by adding a single-use GMP facility for customers. “We are seeing an increasing global demand for end-to-end process development solutions,” says Udit Batra, CEO of MilliporeSigma, Merck’s life sciences business.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment